MANDALAY RESOURCES CORP (MND.CA) Fundamental Analysis & Valuation

TSX:MND • CA5625684025

Current stock price

5.4 CAD
+0.29 (+5.68%)
Last:

This MND.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. MND.CA Profitability Analysis

1.1 Basic Checks

  • MND had positive earnings in the past year.
  • In the past year MND had a positive cash flow from operations.
  • In the past 5 years MND has always been profitable.
  • Each year in the past 5 years MND had a positive operating cash flow.
MND.CA Yearly Net Income VS EBIT VS OCF VS FCFMND.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 15.21%, MND belongs to the top of the industry, outperforming 95.34% of the companies in the same industry.
  • With an excellent Return On Equity value of 22.08%, MND belongs to the best of the industry, outperforming 95.59% of the companies in the same industry.
  • MND's Return On Invested Capital of 19.39% is amongst the best of the industry. MND outperforms 97.73% of its industry peers.
  • MND had an Average Return On Invested Capital over the past 3 years of 11.24%. This is below the industry average of 13.35%.
  • The last Return On Invested Capital (19.39%) for MND is above the 3 year average (11.24%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROIC 19.39%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
MND.CA Yearly ROA, ROE, ROICMND.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • The Profit Margin of MND (21.54%) is better than 95.09% of its industry peers.
  • In the last couple of years the Profit Margin of MND has declined.
  • MND has a Operating Margin of 37.25%. This is amongst the best in the industry. MND outperforms 96.10% of its industry peers.
  • In the last couple of years the Operating Margin of MND has grown nicely.
  • MND's Gross Margin of 43.15% is amongst the best of the industry. MND outperforms 93.58% of its industry peers.
  • In the last couple of years the Gross Margin of MND has grown nicely.
Industry RankSector Rank
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
MND.CA Yearly Profit, Operating, Gross MarginsMND.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. MND.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MND is creating value.
  • MND has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, MND has more shares outstanding
  • MND has a better debt/assets ratio than last year.
MND.CA Yearly Shares OutstandingMND.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MND.CA Yearly Total Debt VS Total AssetsMND.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 4.07 indicates that MND is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.07, MND is in the better half of the industry, outperforming 60.96% of the companies in the same industry.
  • MND has a debt to FCF ratio of 0.12. This is a very positive value and a sign of high solvency as it would only need 0.12 years to pay back of all of its debts.
  • MND has a Debt to FCF ratio of 0.12. This is amongst the best in the industry. MND outperforms 96.85% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that MND is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.02, MND is in line with its industry, outperforming 45.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Altman-Z 4.07
ROIC/WACC2.16
WACC8.96%
MND.CA Yearly LT Debt VS Equity VS FCFMND.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • MND has a Current Ratio of 2.32. This indicates that MND is financially healthy and has no problem in meeting its short term obligations.
  • MND has a Current ratio (2.32) which is comparable to the rest of the industry.
  • MND has a Quick Ratio of 1.93. This is a normal value and indicates that MND is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MND (1.93) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.93
MND.CA Yearly Current Assets VS Current LiabilitesMND.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MND.CA Growth Analysis

3.1 Past

  • MND shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 370.59%, which is quite impressive.
  • MND shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.42% yearly.
  • Looking at the last year, MND shows a very strong growth in Revenue. The Revenue has grown by 40.99%.
  • MND shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.42% yearly.
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%

3.2 Future

  • MND is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.09% yearly.
  • The Revenue is expected to decrease by -1.40% on average over the next years.
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue Next Year10.01%
Revenue Next 2Y6.82%
Revenue Next 3Y0.03%
Revenue Next 5Y-1.4%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MND.CA Yearly Revenue VS EstimatesMND.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
MND.CA Yearly EPS VS EstimatesMND.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

8

4. MND.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 4.91, the valuation of MND can be described as very cheap.
  • Based on the Price/Earnings ratio, MND is valued cheaper than 97.48% of the companies in the same industry.
  • MND's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.51.
  • A Price/Forward Earnings ratio of 5.24 indicates a rather cheap valuation of MND.
  • 96.22% of the companies in the same industry are more expensive than MND, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 21.41. MND is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.91
Fwd PE 5.24
MND.CA Price Earnings VS Forward Price EarningsMND.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MND is valued cheaply inside the industry as 99.12% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, MND is valued cheaply inside the industry as 98.61% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.88
EV/EBITDA 2.18
MND.CA Per share dataMND.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MND does not grow enough to justify the current Price/Earnings ratio.
  • MND has an outstanding profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as MND's earnings are expected to decrease with -9.00% in the coming years.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y7.23%
EPS Next 3Y-9%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MND.CA Dividend Analysis

5.1 Amount

  • No dividends for MND!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MND.CA Fundamentals: All Metrics, Ratios and Statistics

MANDALAY RESOURCES CORP

TSX:MND (8/6/2025, 7:00:00 PM)

5.4

+0.29 (+5.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength85.16
Industry Growth20.9
Earnings (Last)08-05
Earnings (Next)11-04
Inst Owners49.88%
Inst Owner ChangeN/A
Ins Owners2.16%
Ins Owner ChangeN/A
Market Cap511.16M
Revenue(TTM)263.21M
Net Income(TTM)56.70M
Analysts80
Price Target7.14 (32.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.98%
Min EPS beat(2)-5.49%
Max EPS beat(2)41.44%
EPS beat(4)3
Avg EPS beat(4)58%
Min EPS beat(4)-5.49%
Max EPS beat(4)117.82%
EPS beat(8)5
Avg EPS beat(8)4.3%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.88%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)3.05%
Revenue beat(4)2
Avg Revenue beat(4)5.48%
Min Revenue beat(4)-2.25%
Max Revenue beat(4)22.41%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.45%
EPS NQ rev (1m)26.67%
EPS NQ rev (3m)18.75%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)5.96%
Revenue NY rev (3m)5.96%
Valuation
Industry RankSector Rank
PE 4.91
Fwd PE 5.24
P/S 1.41
P/FCF 5.88
P/OCF 3.33
P/B 1.44
P/tB 1.44
EV/EBITDA 2.18
EPS(TTM)1.1
EY20.37%
EPS(NY)1.03
Fwd EY19.09%
FCF(TTM)0.92
FCFY17.02%
OCF(TTM)1.62
OCFY30%
SpS3.83
BVpS3.74
TBVpS3.74
PEG (NY)1.92
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 15.21%
ROE 22.08%
ROCE 31.66%
ROIC 19.39%
ROICexc 27.12%
ROICexgc 27.12%
OM 37.25%
PM (TTM) 21.54%
GM 43.15%
FCFM 23.96%
ROA(3y)8.49%
ROA(5y)9.17%
ROE(3y)12.53%
ROE(5y)15.1%
ROIC(3y)11.24%
ROIC(5y)13.24%
ROICexc(3y)14.44%
ROICexc(5y)16.27%
ROICexgc(3y)14.44%
ROICexgc(5y)16.27%
ROCE(3y)18.36%
ROCE(5y)21.62%
ROICexgc growth 3Y6.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y6.04%
ROICexc growth 5YN/A
OM growth 3Y3.55%
OM growth 5YN/A
PM growth 3Y-6.05%
PM growth 5YN/A
GM growth 3Y2.91%
GM growth 5YN/A
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.12
Debt/EBITDA 0.04
Cap/Depr 138.52%
Cap/Sales 18.28%
Interest Coverage 94.28
Cash Conversion 83.73%
Profit Quality 111.25%
Current Ratio 2.32
Quick Ratio 1.93
Altman-Z 4.07
F-Score9
WACC8.96%
ROIC/WACC2.16
Cap/Depr(3y)122.26%
Cap/Depr(5y)123.51%
Cap/Sales(3y)21.13%
Cap/Sales(5y)21.9%
Profit Quality(3y)111.23%
Profit Quality(5y)107.72%
High Growth Momentum
Growth
EPS 1Y (TTM)370.59%
EPS 3Y8.42%
EPS 5YN/A
EPS Q2Q%250%
EPS Next Y2.55%
EPS Next 2Y7.23%
EPS Next 3Y-9%
EPS Next 5Y-3.09%
Revenue 1Y (TTM)40.99%
Revenue growth 3Y1.61%
Revenue growth 5Y17.42%
Sales Q2Q%40.63%
Revenue Next Year10.01%
Revenue Next 2Y6.82%
Revenue Next 3Y0.03%
Revenue Next 5Y-1.4%
EBIT growth 1Y218.33%
EBIT growth 3Y5.22%
EBIT growth 5YN/A
EBIT Next Year39.15%
EBIT Next 3Y9.81%
EBIT Next 5Y0.91%
FCF growth 1Y363.77%
FCF growth 3Y69.59%
FCF growth 5YN/A
OCF growth 1Y112.12%
OCF growth 3Y22.03%
OCF growth 5Y71.54%

MANDALAY RESOURCES CORP / MND.CA Fundamental Analysis FAQ

What is the fundamental rating for MND stock?

ChartMill assigns a fundamental rating of 7 / 10 to MND.CA.


Can you provide the valuation status for MANDALAY RESOURCES CORP?

ChartMill assigns a valuation rating of 8 / 10 to MANDALAY RESOURCES CORP (MND.CA). This can be considered as Undervalued.


How profitable is MANDALAY RESOURCES CORP (MND.CA) stock?

MANDALAY RESOURCES CORP (MND.CA) has a profitability rating of 9 / 10.


What are the PE and PB ratios of MANDALAY RESOURCES CORP (MND.CA) stock?

The Price/Earnings (PE) ratio for MANDALAY RESOURCES CORP (MND.CA) is 4.91 and the Price/Book (PB) ratio is 1.44.


What is the financial health of MANDALAY RESOURCES CORP (MND.CA) stock?

The financial health rating of MANDALAY RESOURCES CORP (MND.CA) is 7 / 10.